Access Vascular Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$22M
- Investors
-
4
Access Vascular General Information
Description
Developer of vascular access devices designed to address the most common and costly complications in intravenous therapy. The company's devices use novel hydrogel material without any coating or additive to reduce thrombus accumulation, infection, and phlebitis, and prevent the accumulation of blood components that can lead to blood clots, enabling healthcare providers to increase catheter dwell time and reduce circulatory compromise.
Contact Information
Website
www.accessvascularinc.comCorporate Office
- 749 Middlesex Turnpike
- Billerica, MA 01821
- United States
Corporate Office
- 749 Middlesex Turnpike
- Billerica, MA 01821
- United States
Access Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series C) | 26-Oct-2023 | $22M | Completed | Generating Revenue | ||
| 7. Later Stage VC | 19-Oct-2022 | Cancelled | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 03-Mar-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A1) | 06-Sep-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 23-Aug-2018 | Completed | Generating Revenue | |||
| 3. Seed Round | 16-Aug-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jun-2017 | $1.2M | Completed | Startup | ||
| 1. Seed Round | 04-Feb-2016 | $1.2M | $1.2M | Completed | Startup |
Access Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed B | ||||||||
| Seed A | 1,706,484 | $0.000100 | $0.29 | $0.29 | 1x | $0.29 | 1.89% | |
| Seed | 1,158,011 | $0.000100 | $0.21 | $0.21 | 1x | $0.21 | 1.28% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Access Vascular Comparisons
Industry
Financing
Details
Access Vascular Competitors (15)
One of Access Vascular’s 15 competitors is Advent Access, a Venture Capital-Backed company based in Singapore, Singapore.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Advent Access | Venture Capital-Backed | Singapore, Singapore | ||||
| Elucent Medical | Private Equity-Backed | Eden Prairie, MN | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Laminate Medical Technologies | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Mediflex | Corporation | Islandia, NY |
Access Vascular Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Access Vascular Patents
Access Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240399119-A1 | Catheter tip formation methods | Pending | 10-Mar-2023 | ||
| US-20240399120-A1 | Material binding compositions and related methods | Pending | 10-Mar-2023 | ||
| US-20240399031-A1 | Intravenous catheters and related methods | Pending | 10-Mar-2023 | ||
| CA-3183979-A1 | Articles comprising markings and related methods | Pending | 30-Jun-2020 | ||
| AU-2021300951-A1 | Articles comprising markings and related methods | Pending | 30-Jun-2020 | A61M25/0105 |
Access Vascular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Access Vascular Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Green Park & Golf Ventures | Venture Capital | Minority | ||
| TVM Capital Life Science | Venture Capital | Minority | ||
| AngelMD | Angel Group | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority |
Access Vascular FAQs
-
When was Access Vascular founded?
Access Vascular was founded in 2015.
-
Where is Access Vascular headquartered?
Access Vascular is headquartered in Billerica, MA.
-
What is the size of Access Vascular?
Access Vascular has 42 total employees.
-
What industry is Access Vascular in?
Access Vascular’s primary industry is Surgical Devices.
-
Is Access Vascular a private or public company?
Access Vascular is a Private company.
-
What is the current valuation of Access Vascular?
The current valuation of Access Vascular is .
-
What is Access Vascular’s current revenue?
The current revenue for Access Vascular is .
-
How much funding has Access Vascular raised over time?
Access Vascular has raised $54.3M.
-
Who are Access Vascular’s investors?
Green Park & Golf Ventures, TVM Capital Life Science, AngelMD, and MedTech Innovator have invested in Access Vascular.
-
Who are Access Vascular’s competitors?
Advent Access, Elucent Medical, Spine Wave, Laminate Medical Technologies, and Mediflex are some of the 15 competitors of Access Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
